Fetoplacental weight ratio is defined as fetal weight divided by placental weight. This ratio varies according to gestational age and depends on various disorders complicating pregnancy. This study was done in Government Maternity Hospital, Sultan bazaar, Hyderabad on 120 term patients between January 2016 to March 2016. After preliminary examination and investigations, patients were divided into 3 groups: normotensive (Group A), gestational hypertension (Group B), preeclampsia and eclampsia (Group C). Fetal weight and Placental weight was recorded on all these patients and Fetoplacental (F: P) ratio was calculated. This study aims to find out the change in F: P weight ratio in hypertensive disorders of pregnancies. This study concludes that mean weight of both fetus and placenta are both reduced and hence F: P ratio is constant even in hypertensive disorders.
BACKGROUND Ectopic gestation though potentially life threating, timely diagnosis and appropriate treatment can reduce the risk of maternal mortality and morbidity. The benefits of medical therapy particularly with single dose methotrexate and the cure rate are high. The objective of the study was to explore the efficiency of medical management with single-dose methotrexate in unruptured ectopic gestation. MATERIALS AND METHODS Women with an ectopic pregnancy, meeting the criteria for medical treatment were included in the study. All the patients were hospitalized. The protocol was a single dose of methotrexate 50mg IM or 1 mg/kg body weight. All the patients were reviewed after 4 days. If the beta-HCG level drops by 15%, then the women were reviewed weekly until the HCG level falls to less than 5 IU/L. The 2 nd dose was given if the HCG falls below 15% or if there is no drop. RESULTS The overall success rate of single-dose methotrexate was 64%. 2 nd dose methotrexate was required in 11% of patients. In 25% of the cases, surgery was required. Laparoscopic procedure was done in 12% of cases and emergency laparotomy was performed in 13% of the cases. CONCLUSION Single-dose methotrexate therapy is effective in a selected group of patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.